Skip to main content
TipRanks
Go Ultimate75% OFF

Vireo Growth (K95) Q3 2026 Earnings Report

1 Followers

DE:K95 Q3 2026 EPS Results

Actual EPS
-EUR 0.31
Consensus EPS
EUR 0.20
Beat/Miss
Missed by -EUR 0.51
One Year Ago EPS
-EUR 0.50

DE:K95 Q3 2026 Revenue Results

Actual Revenue
EUR 225.76M
Expected Revenue
EUR 208.75M
Beat/Miss
Beat by +EUR 17.00M
YoY Revenue Growth
+181.38%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/10/2026
Time
Before Open
Conference Call
Tuesday, November 10, 2026
DE:K95 Upcoming Earnings

Vireo Growth's next earnings date is estimated for March 24, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:K95 Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 10, 2026|% Change Since:3.74%|
Earnings Call Sentiment|Positive

The call was predominantly positive, supported by 177% year-over-year reported revenue growth, 68.1% adjusted EBITDA growth, improving operating income, a more than $1 billion annualized GAAP revenue run rate, successful acquisitions, strong Florida momentum, and formal near-term guidance. The main challenges were a temporary Minnesota supply-driven decline, seasonality, regulatory approval requirements, lower margins in competitive markets, moderate same-store growth amid cannabis price declines, and ongoing regulatory and acquisition-timing uncertainty.

Company Guidance

For the fourth quarter of 2026, based on current expectations and information available to the company today, including an expected sequential decline in seasonality in our non-cannabis business, Vireo projects revenue to be in the range of $250 million to $265 million and adjusted EBITDA to be in the range of $45 million to $48 million, excluding pending acquisitions that have not yet closed; had they closed prior to the start of the quarter, they could have contributed an additional $45 million to $55 million of revenue and $5 million to $6 million of adjusted EBITDA. For the first quarter of 2027, the company expects revenue to be in the range of $280 million to $300 million and adjusted EBITDA to be in the range of $53 million to $56 million, again excluding pending acquisitions; if they were to close prior to the start of the quarter, those acquisitions could contribute an additional $50 million to $60 million of revenue and $7 million to $8 million of adjusted EBITDA. Fourth quarter 2026 and first quarter 2027 guidance includes the addition of FLUENT Financials beginning November 9; if Vireo remains on a similar path of acquisitions, it will provide formal guidance on a sequential quarterly basis and will not provide full year targets.

  • Acquisition Execution and Platform ExpansionDuring the quarter, Vireo completed the acquisition of PharmaCann Colorado, closed its acquisitions of C21 Investments, including Silver State operations, and M3 Wellness in Nevada, and entered into a management services agreement related to Colorado cannabis assets pending regulatory approvals. On November 9, the company closed the Fluent acquisition, expanding its Florida operations. Previously announced transactions involving Planet 13, select cannabis company assets, and expansion into Ohio continued progressing through regulatory approval processes.
  • Strong Third-Quarter Revenue GrowthThird-quarter GAAP revenue was $253.7 million, an increase of 177% year-over-year on a reported basis. Pro forma revenue, giving effect to certain acquisitions as if completed on July 1, 2026, was $277 million.
  • Improved Adjusted EBITDA and Operating IncomeAdjusted EBITDA was approximately $42.7 million, improving by $17.3 million, or 68.1%, compared with the same period last year. Operating income improved by $13.9 million sequentially during the quarter.
  • Cannabis Retail Revenue GrowthThe cannabis segment delivered 4% pro forma year-over-year retail revenue growth.
  • Fourth-Quarter and First-Quarter Financial OutlookFor the fourth quarter of 2026, Vireo projected revenue of $250 million to $265 million and adjusted EBITDA of $45 million to $48 million. For the first quarter of 2027, the company expects revenue of $280 million to $300 million and adjusted EBITDA of $53 million to $56 million. Both outlooks include FLUENT financials beginning November 9 and exclude pending acquisitions.
  • Additional Pending Acquisition Contribution PotentialIf pending acquisitions had closed before the start of the fourth quarter, the company estimated they could have contributed an additional $45 million to $55 million of revenue and $5 million to $6 million of adjusted EBITDA. For the first quarter of 2027, the estimated potential contribution was an additional $50 million to $60 million of revenue and $7 million to $8 million of adjusted EBITDA.
  • Florida Retail MomentumFlorida retail revenue increased 34% quarter-over-quarter. Management attributed the performance to strong supply-side execution in the vertically integrated business, said the company was properly scaled in Florida, and stated that it expected similar growth across the board for the quarters to come.
  • Minnesota Supply Issue ResolvedManagement stated that the Minnesota supply issue had already been resolved, that the company was entering the fourth quarter strong as it opened its second facility, and that it would have the largest footprint in Minnesota.
  • Scale and Annualized Revenue Run RateManagement said Vireo had built a business with an annualized GAAP revenue run rate exceeding $1 billion, supported by operating teams across the country.
  • Share Repurchases and Capital AllocationUnder the NCIB program, Vireo repurchased 216,200 subordinate voting shares for approximately $2.5 million during the third quarter. Management said buying back stock was its first choice for capital deployment and that the company was trying to maximize the program in a responsible way.
  • Real Estate Financing and Owned FacilitiesSubsequent to quarter end, Vireo announced a $60 million real estate term loan with S.S. Commercial Bank at a fixed rate of 8.5%, secured by cultivation and production facilities in New York and Florida. The company owns approximately a dozen cultivation, production, and other facilities, which management said limits exposure to long-term lease obligations.
  • Asset-Light Strategy in Competitive MarketsColorado represented about 25% of retail revenue and California close to 10%. Management said Vireo had acquired four declining businesses and was turning them around, viewed Colorado and California as important to long-term success, and remained asset-light in those states without cultivation operations or plans to add cultivation for the time being.
  • Delivery and Distribution CapabilitiesManagement said Vireo was likely the largest delivery platform in the U.S., covering revenue activity in California, Utah, Nevada, and other states. The company is studying single-trip delivery economics across limited-license and competitive markets and is seeking to develop expertise in delivery and distribution.
  • Disciplined Leverage and Acquisition CriteriaVireo said it would steer away from heavily indebted businesses and that its long-term goal was to remain consistently under 1x EBITDA leverage. Management also said acquisition multiples would need to be much lower than Vireo's own multiple, which it referenced as approximately 3x EBITDA, with acquisition opportunities in the range previously discussed.
  • Operating Model and Synergy OpportunitiesManagement described three operating pillars: local retail execution, shared services such as analytics, finance, and HR, and the supply chain. It cited substantial state-level synergies, a goal that had moved from $100 million to $200 million in each state, and national opportunities in distribution and non-THC products.
  • Capital-Efficient CapEx ApproachManagement said it did not plan to build cultivation facilities, pursue major new retail or cultivation investments, or enter greenfield states through large store builds. Looking forward, it expects OpEx to remain broadly in line with current levels and CapEx to be replacement CapEx rather than new CapEx.
  • Regulatory Barriers and Market PositionManagement acknowledged regulatory uncertainty but said regulatory changes can also serve as barriers to entry. It stated that the company remained above $1,000 per pound and viewed the combination of barriers to entry and Vireo's scale as a favorable setup for competition.

DE:K95 Earnings History

DE:K95 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 24, 20272026 (Q4)0.17--0.49――
Nov 10, 20262026 (Q3)0.20-0.31-0.538.85% (+0.20)
Aug 11, 20262026 (Q2)0.150.21-0.61134.76% (+0.83)
May 12, 20262026 (Q1)0.14-0.36-0.4826.59% (+0.13)
Mar 17, 20262025 (Q4)0.27-0.49-1.9174.10% (+1.41)
Nov 12, 20252025 (Q3)0.27-0.50-0.547.33% (+0.04)
Aug 13, 20252025 (Q2)0.00-0.610―
May 09, 20252025 (Q1)-0.54-0.48-1.3664.40% (+0.88)
Mar 04, 20252024 (Q4)-0.54-1.91-0.82-133.33% (-1.09)
Nov 13, 20242024 (Q3)-0.54-0.54-0.939.46% (+0.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed